M&A Deal Summary |
|
|---|---|
| Date | 2021-01-28 |
| Target | Vera Therapeutics - Gene Modulating Technology |
| Sector | Life Science |
| Buyer(s) | NeuBase Therapeutics |
| Sellers(s) | Vera Therapeutics |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2009 |
| Sector | Life Science |
| Employees | 15 |
NeuBase Therapeutics is a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases. NeuBase Therapeutics was founded in 2009 and is based in Pittsburgh, Pennsylvania.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-01-03 |
NeuBase Therapeutics
Pittsburgh, Pennsylvania, United States NeuBase Therapeutics, Inc. (old) is a developer of modular peptide-nucleic acid antisense oligonucleotide (PATrOL™) platform to address genetic diseases caused by mutant proteins with a single, cohesive approach. |
Buy | - |
| Category | Company |
|---|---|
| Sector | Life Science |
Vera Therapeutics is a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases that improve patients' lives. Vera Therapeutics is based in South San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
